Clinical Trial Update: Study of Weekly Cabazitaxel for Advanced Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of weekly cabazitaxel for advanced prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Jevtana (cabazitaxel)

Snippet

Sponsor: Spanish Oncology Genito-Urinary Group | Conditions: Hormone Refractory Prostate Cancer | Phase 2 | Status: COMPLETED